Advanced imaging equipment using ionizing radiation enters the global market at the rate of one new technology every five years.

There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower GI bleed embolization procedures.  

An independent heart team blinded to ICA results was able to deliver helpful guidance for CABG procedures for 99.1% of patients using just CCTA and FFR_CT alone. This approach is safe and feasible, researchers wrote, and the next step is to gather additional data. 

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

The Azurion system is designed to swiftly identify stroke-related damage for improved care coordination.

The technique was successful in a proof-of-concept animal study, but human trials are a long way off. 

Heart teams have several options when patients present with stable chest pain and require further testing. According to a brand new analysis of nearly 800 patients, CCTA may be the best place to start. 

The newly approved system was designed to assist clinicians with the detection of Alzheimer's disease and other forms of dementia.